Study of Cyclosporine in Post-LASIK Patients
NCT00991458
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
621
Enrollment
INDUSTRY
Sponsor class
Conditions
Laser In Situ Keratomileusis
Interventions
DRUG:
Cyclosporine 0.010% eye drops
DRUG:
Cyclosporine 0.005% eye drops
DRUG:
Placebo (Vehicle for Cyclosporine)
Sponsor
Allergan